Information:
Fel:
ID
34431
Beskrivning
Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02486354
Länk
https://clinicaltrials.gov/show/NCT02486354
Nyckelord
Versioner (1)
- 2019-01-17 2019-01-17 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
17 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non-small Cell Lung Cancer NCT02486354
Eligibility Non-small Cell Lung Cancer NCT02486354
- StudyEvent: Eligibility
Similar models
Eligibility Non-small Cell Lung Cancer NCT02486354
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
histologically or cytologically confirmed locally advanced/metastatic (stage iiib/stage iv, using the american joint committee on cancer [ajcc] 6th edition of tumor-node-metastasis [tnm] staging system) nsclc patients
boolean
ID.2
Item
progressed after at least one platinum-based chemotherapy regimen at entry
boolean
ID.3
Item
eastern cooperative oncology group (ecog) performance status (ps) 0-2
boolean
ID.4
Item
at least one measurable lesion by response evaluation criteria in solid tumors version 1.0
boolean
ID.5
Item
adequate hematologic and biochemical values
boolean
ID.6
Item
patients with symptomatic brain metastases
boolean
ID.7
Item
malignant tumor within the previous five years
boolean
ID.8
Item
severe infection; congestive heart failure
boolean
ID.9
Item
previous treatment with drugs targeting egfr
boolean
ID.10
Item
history of interstitial lung disease
boolean